HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 196 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $33,000 | -31.2% | 1,932 | -21.1% | 0.00% | 0.0% |
Q1 2018 | $48,000 | +29.7% | 2,450 | +33.4% | 0.00% | 0.0% |
Q4 2017 | $37,000 | +48.0% | 1,836 | +29.2% | 0.00% | 0.0% |
Q3 2017 | $25,000 | +56.2% | 1,421 | +16.8% | 0.00% | 0.0% |
Q2 2017 | $16,000 | +220.0% | 1,217 | +200.5% | 0.00% | – |
Q1 2017 | $5,000 | +25.0% | 405 | +6.6% | 0.00% | – |
Q4 2016 | $4,000 | -20.0% | 380 | 0.0% | 0.00% | – |
Q3 2016 | $5,000 | +66.7% | 380 | 0.0% | 0.00% | – |
Q2 2016 | $3,000 | -88.9% | 380 | -86.3% | 0.00% | -100.0% |
Q2 2014 | $27,000 | +42.1% | 2,779 | +83.4% | 0.00% | +100.0% |
Q1 2014 | $19,000 | – | 1,515 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 14,092,771 | $206,177,000 | 28.12% |
BB BIOTECH AG | 8,322,860 | $121,763,000 | 3.90% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 398,633 | $4,579,000 | 2.84% |
DOHENY ASSET MANAGEMENT /CA | 227,193 | $3,324,000 | 2.43% |
SNYDER CAPITAL MANAGEMENT L P | 2,833,759 | $41,458,000 | 2.24% |
First Light Asset Management, LLC | 938,399 | $13,729,000 | 2.19% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 9,027,164 | $132,067,000 | 1.77% |
Taylor Wealth Management Partners | 204,277 | $2,989,000 | 1.72% |
Sterling Global Strategies LLC | 22,000 | $321,860,000 | 1.63% |
Granite Investment Partners, LLC | 988,939 | $14,468,000 | 1.06% |